MicroVision Reports Director Changes and Compensatory Arrangements

Ticker: MVIS · Form: 8-K · Filed: 2024-09-27T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, officer-changes, director-changes

TL;DR

MicroVision filed an 8-K on 9/27/24 detailing board/officer changes and compensation updates.

AI Summary

MicroVision, Inc. filed an 8-K on September 27, 2024, reporting changes in its board of directors and certain officers, along with updates to compensatory arrangements. The filing also includes financial statements and exhibits, indicating ongoing corporate governance and financial reporting activities for the company.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: low — This filing is a routine corporate disclosure regarding board and officer changes, not indicating immediate financial distress or significant operational shifts.

Key Players & Entities

FAQ

What specific changes were made to the board of directors or certain officers?

The filing indicates "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers" as an item of information, but the specific details of these changes are not provided in the provided text excerpt.

What is the nature of the "Compensatory Arrangements of Certain Officers" mentioned?

The filing lists "Compensatory Arrangements of Certain Officers" as an item of information, suggesting updates or new agreements related to executive pay, but the specifics are not detailed in the excerpt.

What financial statements and exhibits are included with this 8-K filing?

The filing states "Financial Statements and Exhibits" are included, but the specific content of these documents is not detailed in the provided text.

When was MicroVision, Inc. incorporated?

MicroVision, Inc. was incorporated in Delaware, as stated in the filing.

What is the principal executive office address for MicroVision, Inc.?

The principal executive offices are located at 18390 NE 68th Street, Redmond, Washington 98052.

Filing Stats: 499 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2024-09-27 16:40:33

Key Financial Figures

Filing Documents

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED) September 27, 2024 MicroVision, Inc. (Exact name of registrant as specified in its charter) Delaware 001-34170 91-1600822 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 18390 NE 68 th Street Redmond , Washington 98052 (Address of principal executive offices) (Zip code) (425) 936-6847 Registrant's telephone number, including area code Not Applicable (Former name or former address if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading symbol(s) Name of each exchange on which registered Common stock, par value $0.001 per share MVIS The NASDAQ Stock Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 27, 2024, MicroVision, Inc. issued a press release announcing the retirement of a member of the Company's Board of Directors, Brian Turner. His retirement, and related resignation from the Board, was not due to any disagreement with the company or any matter relating to MicroVision's operations, policies, or practices. A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference. Item 9.01. Financial Statements and Exhibits. (c) Exhibits. Pursuant to the rules and regulations of the SEC, the attached exhibit is deemed to have been furnished to, but not filed with, the SEC. Exhibit No. Description 99.1 Press Release of MicroVision, Inc. dated September 27, 2024 104 Cover Page Interactive File (the cover page tags are embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MICROVISION, INC. By: /s/ Drew G. Markham Drew G. Markham Senior Vice President, General Counsel and Secretary Dated: September 27, 2024

View on Read The Filing